New test to detect prostate cancer may be more effective than traditional screening methods
Men are encouraged to buy Flomax to address any changes in their prostate health, which is of utmost concern for millions of Americans.
Men are encouraged to buy Flomax to address any changes in their prostate health, which is of utmost concern for millions of Americans. According to research from the Seidman Cancer Center, the Cleveland Clinic, Veterans Administration Boston Healthcare and the National Cancer Institute, a promising new tool has been developed that could enhance the effectiveness of screening for prostate cancer.
Lead author Mark Stovsky and his colleagues, who published their results in the journal Urology, explained that the PSA/SIA assay may be more sensitive in detecting early signs of the disease, compared to traditional techniques.
The team followed a total of 222 men who received the new diagnostic test. The researchers discovered that the assay had 100 percent sensitivity and 80.3 percent specificity.
"This has the potential to be a major advance in the development of more accurate tests for prostate cancer diagnosis," Stovsky explained. "Prostate cancer is the most common cancer in men but traditional screening is not very accurate. This test provides a new way to look at prostate cancer diagnosis utilizing a novel biological assay which differentiates PSA molecular structures arising from cancer versus non-cancerous glands."
|
